Compare DOX & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DOX | RGEN |
|---|---|---|
| Founded | 1982 | 1981 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.5B | 8.2B |
| IPO Year | 1998 | N/A |
| Metric | DOX | RGEN |
|---|---|---|
| Price | $83.80 | $163.39 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 11 |
| Target Price | $97.00 | ★ $177.18 |
| AVG Volume (30 Days) | ★ 921.0K | 600.1K |
| Earning Date | 02-03-2026 | 02-19-2026 |
| Dividend Yield | ★ 2.52% | N/A |
| EPS Growth | ★ 19.01 | N/A |
| EPS | ★ 5.05 | 0.03 |
| Revenue | ★ $4,532,913,000.00 | $707,890,000.00 |
| Revenue This Year | $4.57 | $17.86 |
| Revenue Next Year | $4.11 | $12.44 |
| P/E Ratio | ★ $16.58 | $5,247.54 |
| Revenue Growth | N/A | ★ 11.74 |
| 52 Week Low | $74.32 | $102.97 |
| 52 Week High | $95.41 | $182.52 |
| Indicator | DOX | RGEN |
|---|---|---|
| Relative Strength Index (RSI) | 64.49 | 48.28 |
| Support Level | $82.38 | $158.80 |
| Resistance Level | $84.39 | $172.51 |
| Average True Range (ATR) | 1.39 | 6.24 |
| MACD | 0.21 | -0.83 |
| Stochastic Oscillator | 83.92 | 25.84 |
Amdocs Ltd is a provider of software and services to communications, cable and satellite, entertainment, and media industry service providers. The Company and its subsidiaries operate in one operating segment, providing software products and services for the communications, entertainment and media industry service being designed, develop, market, support, implement, and operate its open and modular cloud offering. The company offers business support systems, operational support systems, and managed services. Geographically, it derives a majority of revenue from North America and also has a presence in Europe and the Rest of the world.
Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.